Uluru Inc (ULUR) financial statements (2021 and earlier)

Company profile

Business Address 4410 BELTWAY DRIVE
ADDISON, TX 75001
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3334556
Cash and cash equivalents3334556
Receivables0000000
Inventory, net of allowances, customer advances and progress billings0000011
Inventory0000011
Other undisclosed current assets0000000
Total current assets:4445566
Noncurrent Assets
Intangible assets, net (including goodwill)3444444
Intangible assets, net (excluding goodwill)3444444
Deposits noncurrent assets0000000
Total noncurrent assets:4444444
Other undisclosed assets0000000
TOTAL ASSETS:788991011
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2221222
Accounts payable1111222
Accrued liabilities0000000
Interest and dividends payable0000000
Debt111    
Deferred revenue and credits0000
Contract with customer, liability00 
Other undisclosed current liabilities  0    
Total current liabilities:2222222
Noncurrent Liabilities
Long-term debt and lease obligation   1000
Long-term debt, excluding current maturities   1000
Liabilities, other than long-term debt00 0000
Deferred revenue and credits0000
Contract with customer, liability00 
Other undisclosed noncurrent liabilities  0    
Total noncurrent liabilities:0001111
Total liabilities:3332333
Stockholders' equity
Stockholders' equity attributable to parent, including:4566778
Common stock0000000
Additional paid in capital69696969696969
Accumulated deficit(64)(64)(63)(63)(62)(62)(61)
Other undisclosed stockholders' equity attributable to parent     00
Total stockholders' equity:4566778
TOTAL LIABILITIES AND EQUITY:788991011

Income statement (P&L) ($ in millions)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
Revenues0000000
Revenue, net0000
Cost of revenue(0)(0)(0)(0)(0)(0)(0)
Cost of goods and services sold(0)(0)(0)(0)(0)(0)(0)
Gross profit:00000(0)0
Operating expenses(1)(1)(1)(0)(1)(0)(1)
Operating loss:(1)(0)(0)(0)(0)(1)(0)
Nonoperating income (expense)0(0)00(0)(0)0
Investment income, nonoperating0  0000
Foreign currency transaction gain (loss), before tax(0)(0)00(0)(0)0
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(1)(1)(1)(1)(1)(1)(0)
Other undisclosed income from continuing operations before income taxes   0 0 
Net loss available to common stockholders, diluted:(1)(1)(1)(0)(1)(1)(0)

Comprehensive Income ($ in millions)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
Net loss:(1)(1)(1)(0)(1)(1)(0)
Comprehensive loss, net of tax, attributable to parent:(1)(1)(1)(0)(1)(1)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: